Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Presentation THT 2026

Interatrial Shunts: Reflections of a Seasoned Practitioner

Presenter: John R. Teerlink

March 04, 2026

Presentation THT 2026

Anatomic Considerations for T-TEER and TTVR

Presenter: Jörg Hausleiter

March 03, 2026

Presentation THT 2026

Heart Failure Phenotype and Peri-Procedural Cardioversion After TEER: A National Inpatient Analysis

Presenter: Neal Patel

March 03, 2026

Presentation THT 2026

Impact of Baseline Tricuspid Regurgitation on Outcomes in Heart Failure Patients Undergoing Mitral TEER

Presenter: Thitiphan Srikulmontri

March 03, 2026

Presentation THT 2026

NO: The Evidence is Not Strong Enough to Support TEER in Moderate MR in HF

Presenter: Gregg W. Stone

March 02, 2026

Presentation THT 2026

YES: TEER is Totally Appropriate for Patients With Moderate MR if HF

Presenter: Stefan Anker

March 02, 2026

Presentation THT 2024

Case 5: Tricuspid TEER for the Win

Presenter: Sameer Gafoor

March 05, 2024

Presentation THT 2024

Case 3: Mitral TEER With Consequences

Presenter: Soundos Moualla

March 05, 2024

Presentation THT 2024

Post-TEER Nonresponders: Is Cardiomems a Meaningful Option?

Presenter: Nir Uriel

March 04, 2024

Presentation THT 2024

Impact of Mitral TEER on Cardiomechanics and Energetics

Presenter: Nicolas M. Van Mieghem

March 04, 2024

Presentation THT 2023

Acute MR With MCS/TEER

Presenter: Thomas Waggoner

March 21, 2023

Presentation THT 2023

Beyond the Four Foundational Therapies: Vericiguat and Omecamtiv Mecarbil

Presenter: John Teerlink

March 20, 2023

Presentation THT 2022

Percutanous Mitral Valve Repair Devices (Mitral TEER vs Annuloplasty/Chordal Suspension)

Presenter: Mark Reisman

February 02, 2022

Presentation THT 2022

Omecamtiv Mecarbil - Is It More Effective in Low EFs

Presenter: John Teerlink

February 01, 2022

Advertisement

Interatrial Shunts: Reflections of a Seasoned Practitioner

Anatomic Considerations for T-TEER and TTVR

Heart Failure Phenotype and Peri-Procedural Cardioversion After TEER: A National Inpatient Analysis

Impact of Baseline Tricuspid Regurgitation on Outcomes in Heart Failure Patients Undergoing Mitral TEER

NO: The Evidence is Not Strong Enough to Support TEER in Moderate MR in HF

YES: TEER is Totally Appropriate for Patients With Moderate MR if HF

Case 5: Tricuspid TEER for the Win

Case 3: Mitral TEER With Consequences

Post-TEER Nonresponders: Is Cardiomems a Meaningful Option?

Impact of Mitral TEER on Cardiomechanics and Energetics

Acute MR With MCS/TEER

Beyond the Four Foundational Therapies: Vericiguat and Omecamtiv Mecarbil

Percutanous Mitral Valve Repair Devices (Mitral TEER vs Annuloplasty/Chordal Suspension)

Omecamtiv Mecarbil - Is It More Effective in Low EFs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content